Draxis Health Inc /CN/ - Report of Foreign Issuer (6-K)
17 März 2008 - 8:08PM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15-d-16 of
The Securities Exchange Act of 1934
For March 17, 2008
Commission File Number 000-17434
DRAXIS
HEALTH INC.
(Translation of registrants name into English)
Suite 4700, TD Bank Tower
Toronto Dominion Centre
Toronto, Ontario M5K 1E6
CANADA
(Address of principal offices)
Registrant files annual reports under cover of Form 20-F
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.
DRAXIS HEALTH INC.
By:/s/
Alida Gualtieri
|
General
Counsel & Secretary
|
Dated:
March17,2008
2
Draxis Health (MM) (NASDAQ:DRAX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Draxis Health (MM) (NASDAQ:DRAX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über Draxis Health (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Draxis Health Inc /CN/ News-Artikel